Should celecoxib be contraindicated in patients who are allergic to sulfonamides?

Drug Safety

Volumn 25, Issue 4, 2002, Pages 297-300

  Knowles, Sandra ^a,b   Shapiro, Lori ^a,b   Shear, Neil H ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DIURETIC AGENT; FUROSEMIDE; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PLACEBO; ROFECOXIB; SULFADIMETHOXINE; SULFONAMIDE; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT;

ANGIONEUROTIC EDEMA; ARTHRITIS; CLINICAL TRIAL; CROSS REACTION; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG STRUCTURE; HUMAN; LETTER; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; STEVENS JOHNSON SYNDROME; SYNDROME DELINEATION; TOXIC EPIDERMAL NECROLYSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; HUMANS; META-ANALYSIS; PYRAZOLES; RISK FACTORS; SAMPLE SIZE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 0036264670     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200225040-00007     Document Type: Letter

References (6)

1. 1. M Rieder J Uetrecht N Shear 1989 Diagnosis of sulfonamide hypersensitivity reactions by in-vitro ‘rechallenge’ with hydroxylamine metabolites Ann Intern Med 110 286 9 2913915 1:STN:280:DyaL1M7hs1Ogsw%3D%3D Rieder M, Uetrecht J, Shear N, et al. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro ‘rechallenge’ with hydroxylamine metabolites. Ann Intern Med 1989; 110: 286–9
2. 2. N Shear S Spielberg 1988 Anticonvulsant hypersensitivity syndrome, in vitro assessment of risk J Clin Invest 82 1826 32 3198757 10.1172/JCI113798 1:CAS:528:DyaL1MXltFaitg%3D%3D Shear N, Spielberg S. Anticonvulsant hypersensitivity syndrome, in vitro assessment of risk. J Clin Invest 1988; 82: 1826–32
3. 3. J Uetrecht 2000 Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions? Curr Drug Metab 1 133 41 11465079 10.2174/1389200003339081 1:CAS:528:DC%2BD3cXntlOrs7w%3D Uetrecht J. Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions? Curr Drug Metab 2000; 1: 133–41
4. 4. B Wiholm 2001 Identification of sulfonamide-like adverse drug reactions to celecoxib in the World Health Organization Database Curr Med Research Opinion 17 210 6 1:CAS:528:DC%2BD38XkslSmsg%3D%3D Wiholm B. Identification of sulfonamide-like adverse drug reactions to celecoxib in the World Health Organization Database. Curr Med Research Opinion 2001; 17: 210–6
5. 5. B Stricker C Biriell 1987 Skin reactions and fever with indapamide BMJ 295 1313 4 2961407 10.1136/bmj.295.6609.1313 1:STN:280:DyaL1c%2FnvFSrtg%3D%3D Stricker B, Biriell C. Skin reactions and fever with indapamide. BMJ 1987; 295: 1313–4
6. 6. J Smith J Johnson L Cluff 1966 Studies on the epidemiology of adverse drug reactions N Engl J Med 274 998 5909744 10.1056/NEJM196605052741804 1:STN:280:DyaF287htVajtg%3D%3D Smith J, Johnson J, Cluff L. Studies on the epidemiology of adverse drug reactions. N Engl J Med 1966; 274: 998